Veterinary Medicines

Eurican DAPPI-LR, lyophilisate and suspension for injection

Authorised
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Download as PDF

Product identification

Medicine name:
Eurican DAPPI-LR, lyophilisate and suspension for injection
Eurican DAPPI-LR, лиофилизат и суспензия за инжекциона суспензия
Active substance:
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain CGF 2004/75, Live
    4.70
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, strain CAG2, Live
    4.90
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, strain DK13, Live
    2.50
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine distemper virus, strain BA5, Live
    4.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2205
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 16/12/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 16/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 16/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."